Empower Opioid Misuse & Chronic Pain

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

March 21, 2022

Study Completion Date

March 21, 2022

Conditions
Chronic PainOpioid Use
Interventions
DEVICE

Empower Neuromodulation System Transcutaneous Electrical Nerve Stimulation

Participants will self-administer treatment with the Empower device two times daily for two weeks. Participants will complete surveys over the two-week period to evaluate the effects of the Empower treatment.

Trial Locations (1)

94121

San Francisco VA Medical Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04184362 - Empower Opioid Misuse & Chronic Pain | Biotech Hunter | Biotech Hunter